Medical News

RSS

OSI Pharmaceuticals' 2% Senior Subordinated Notes to remain convertible through July 6, 2010

OSI Pharmaceuticals, Inc. announced today that its 2% Convertible Senior Subordinated Notes due 2025 (the "notes") are convertible at the option of the holders and will remain convertible at least through July 6, 2010, as provided for in the Indenture governing the notes.

5 Jun 2010

COBRA subsidy starts running out for some as Congress grapples with extension

Howard Kornblum has been watching every penny for the past 15 months and it's about to get worse. After being laid off from his job as a consulting director in Michigan, he took advantage in March 2009 of a federal subsidy to help pay for health insurance.

5 Jun 2010

John Theurer Cancer Center to showcase treatment advancements for cancer at ASCO 2010

The John Theurer Cancer Center at Hackensack University Medical Center announced today important research findings that will be presented at the American Society of Clinical Oncology annual meeting taking place June 4 - 8, 2010 in Chicago. Research highlights include a comparison of first-line treatments for an aggressive form of lymphoma, the efficacy and safety of a new genetically engineered cancer therapy, and the value of a commonly used tool for staging lymphoma.

5 Jun 2010

Acute neurological toxicity associated with chronic neurological toxicity in patients with high-grade gliomas

Patients with high-grade gliomas who experience acute (early) neurological toxicity during their treatment were more likely to experience chronic (late) neurological toxicity and shortened overall survival, according to researchers from the Kimmel Cancer Center at Jefferson. The study will be presented at the 2010 ASCO Annual Meeting in Chicago (Abstract #2037).

5 Jun 2010

WRNp controls key step in pluripotent stem cell differentiation: Study

A gene shown to play a role in the aging process appears to play a role in the regulation of the differentiation of embryonic stem cells, according to researchers from the Center for Stem Cell Biology and Regenerative Medicine and the Department of Medicine at Thomas Jefferson University.

5 Jun 2010

South Africa prepares health systems for World Cup disaster — but could be overwhelmed

The Associated Press: South Africa is attempting to prepare its emergency services in case of a disaster at the World Cup, which begins next week. "But the public system won't have to cope alone, the chief medical officer for local tournament organizers said in an interview this week. Dr. Victor Ramathesele outlined plans for what he said would be unprecedented coordination between the public system, the military and the private sector in case of emergency during Africa's first World Cup."

5 Jun 2010

Green tea component reduces leukemia cells in patients with CLL

An extract of green tea appears to have clinical activity with low toxicity in chronic lymphocytic leukemia (CLL) patients who used it in a phase II clinical trial, say researchers at Mayo Clinic.

5 Jun 2010

British PM calls for G8, G20 to reduce maternal mortality, announces new health worker training fund

In a Guardian opinion piece, published on Thursday, British Prime Minister David Cameron says G8 and G20 nations should reduce maternal mortality in developing countries and set "'an ambitious target' of saving three million more lives by 2015," the Guardian reports (Watt, 6/3).

5 Jun 2010

Onyx presents interim results of Phase 1b dose-escalation carfilzomib combination trial for multiple myeloma

Onyx Pharmaceuticals, Inc. today announced updated interim results of the Phase 1b dose-escalation trial, known as the 006 study, evaluating carfilzomib in combination with lenalidomide (Revlimid®) and low dose dexamethasone in patients with relapsed and/or refractory myeloma. These data are being presented today at the 46th American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

5 Jun 2010

Positive results from Phase 2, open-label ENCORE 303 trial to be presented at ASCO 2010

Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, reported final results from the Phase 2, open-label ENCORE 303 trial in post-menopausal women with advanced, estrogen receptor positive breast cancer who were progressing on aromatase inhibitor therapy.

5 Jun 2010

Sebelius defends Berwick for CMS post

The Wall Street Journal: HHS Secretary Kathleen Sebelius "Thursday rejected criticism of the Obama administration's nominee to run Medicare and Medicaid, saying Republicans were being unfair to Donald Berwick and she was confident he would be confirmed. Dr. Berwick, a Harvard pediatrician and health-quality advocate, has come under sharp attack from Republicans over his ties to Britain's national health system and past writings about how to make health care more efficient.

5 Jun 2010

Encore Path signs license agreement for UMB technology that helps stroke patients redevelop natural gait

The University of Maryland, Baltimore's Office of Research and Development announced that Encore Path, Inc. of Baltimore signed an exclusive worldwide license agreement for a device technology invented jointly by researchers at the University of Maryland, Baltimore and the University of Maryland Baltimore County that helps stroke patients retrain their bodies to walk.

5 Jun 2010

HHF to open Terni Human Health Bioscience Institute

The Human Health Foundation, a nonprofit organization founded in 2006 to develop and fund biomedical research in Italy, will open the Terni Human Health Bioscience Institute for the investigation of breast, brain and lung cancer on June 7th in Terni, Italy.

5 Jun 2010

Survey: Group insurance rates rise for employers

"Group health insurance rates for small and midsize employers are surging for 2011 renewals, according to a survey by the Council of Insurance Agents & Brokers," Business Insurance reports.

5 Jun 2010

PEB's European licensee SDX completes clinical trial for prognostic gene signature for colorectal cancer

Pacific Edge (PEB), a New Zealand-based biomedical company, today announced the successful completion of the European clinical trial for their prognostic gene signature for colorectal cancer. The clinical trial results showed a successful outcome that enables patients diagnosed with UICC stage II or UICC stage III colorectal cancer and with a high risk of disease progression to be identified and treated more appropriately.

5 Jun 2010

VA partners with National Institutes of Health to research on Parkinson's disease

Veterans and others with Parkinson's disease who undergo deep brain stimulation may benefit from research co-sponsored by the Department of Veterans Affairs and published recently in the prestigious New England Journal of Medicine.

5 Jun 2010

RTU announces phase 2 clinical trial results of UF-021 in patients with retinitis pigmentosa

Sucampo Pharmaceuticals, Inc. today confirmed that its partner, R-Tech Ueno, Ltd. reported the results of its recently completed phase 2 clinical trial of UF-021 in retinitis pigmentosa patients. The results showed improvement in visual function dose-dependently in both visual field test and subjective findings.

5 Jun 2010

Insurers, White House bound by need to make overhaul a success

Although the Obama administration and insurance industry had opposing views on aspects of the health bill that Congress eventually passed, they have now found their fortunes bound together as both work to make the overhaul successful, The New York Times reports. "The political fortunes of President Obama and Congressional Democrats depend on their ability to translate its promise into reality for voters, by reining in health costs and making insurance available to everyone at an affordable price.

5 Jun 2010

Obama sets town hall meeting with seniors to tout Medicare rebate checks

President Barack Obama has scheduled a televised town hall meeting Tuesday in Wheaton, Md., "to trumpet one of the most popular provisions of his landmark health care bill: a $250 rebate to help Medicare beneficiaries pay for prescription drugs. ... An estimated 80,000 checks are scheduled to be sent in June, with others to follow on a rolling basis, to Medicare beneficiaries who enter the so-called 'doughnut hole' - a gap in prescription drug coverage that requires them to pay out of pocket" (Stolberg, 6/3).

5 Jun 2010

Endologix named as Orange County's Outstanding Company in Medical Technology

Endologix, Inc., developer of minimally invasive treatments for aortic disorders, announced today that TechAmerica has named Endologix as Orange County's Outstanding Company in Medical Technology. The award was presented to Endologix at the 17th Annual TechAmerica High-Tech Innovation Awards on June 2, 2010 in Irvine, CA.

5 Jun 2010

Medical News

OSI Pharmaceuticals' 2% Senior Subordinated Notes to remain convertible through July 6, 2010

COBRA subsidy starts running out for some as Congress grapples with extension

John Theurer Cancer Center to showcase treatment advancements for cancer at ASCO 2010

Acute neurological toxicity associated with chronic neurological toxicity in patients with high-grade gliomas

WRNp controls key step in pluripotent stem cell differentiation: Study

South Africa prepares health systems for World Cup disaster — but could be overwhelmed

Green tea component reduces leukemia cells in patients with CLL

British PM calls for G8, G20 to reduce maternal mortality, announces new health worker training fund

Onyx presents interim results of Phase 1b dose-escalation carfilzomib combination trial for multiple myeloma

Positive results from Phase 2, open-label ENCORE 303 trial to be presented at ASCO 2010

Sebelius defends Berwick for CMS post

Encore Path signs license agreement for UMB technology that helps stroke patients redevelop natural gait

HHF to open Terni Human Health Bioscience Institute

Survey: Group insurance rates rise for employers

PEB's European licensee SDX completes clinical trial for prognostic gene signature for colorectal cancer

VA partners with National Institutes of Health to research on Parkinson's disease

RTU announces phase 2 clinical trial results of UF-021 in patients with retinitis pigmentosa

Insurers, White House bound by need to make overhaul a success

Obama sets town hall meeting with seniors to tout Medicare rebate checks

Endologix named as Orange County's Outstanding Company in Medical Technology

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Latest News